George Kemble, the Executive Chairman of $SGMT, sold 37,688 shares of the company on 11-20-2025 for an estimated $289,979. We received data on the trade from a recent SEC filing. This was a sale of approximately 31.8% of their shares of this class of stock. Following this trade, they now own 81,005 shares of this class of $SGMT stock.
$SGMT Insider Trading Activity
$SGMT insiders have traded $SGMT stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $SGMT stock by insiders over the last 6 months:
- DAVID HAPPEL (President & CEO) sold 65,478 shares for an estimated $598,115
- GEORGE KEMBLE (Executive Chairman) sold 37,688 shares for an estimated $289,979
- ELIZABETH ROZEK (General Counsel and CCO) sold 10,780 shares for an estimated $98,470
- EDUARDO BRUNO MARTINS (Chief Medical Officer) sold 8,277 shares for an estimated $75,607
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$SGMT Hedge Fund Activity
We have seen 41 institutional investors add shares of $SGMT stock to their portfolio, and 52 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- POINT72 ASSET MANAGEMENT, L.P. removed 1,755,143 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $13,374,189
- ALYESKA INVESTMENT GROUP, L.P. removed 1,192,443 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $9,086,415
- WOODLINE PARTNERS LP removed 1,051,179 shares (-41.2%) from their portfolio in Q3 2025, for an estimated $7,211,087
- ROCK SPRINGS CAPITAL MANAGEMENT LP removed 787,808 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $6,003,096
- MILLENNIUM MANAGEMENT LLC added 700,737 shares (+926.4%) to their portfolio in Q3 2025, for an estimated $4,807,055
- D. E. SHAW & CO., INC. added 557,393 shares (+387.5%) to their portfolio in Q3 2025, for an estimated $3,823,715
- SCHONFELD STRATEGIC ADVISORS LLC added 430,644 shares (+462.4%) to their portfolio in Q3 2025, for an estimated $2,954,217
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$SGMT Analyst Ratings
Wall Street analysts have issued reports on $SGMT in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citizens issued a "Market Outperform" rating on 11/14/2025
- Clear Street issued a "Buy" rating on 10/22/2025
- Canaccord Genuity issued a "Buy" rating on 10/02/2025
- Wedbush issued a "Outperform" rating on 08/11/2025
- HC Wainwright & Co. issued a "Buy" rating on 08/07/2025
- Jones Trading issued a "Buy" rating on 06/06/2025
To track analyst ratings and price targets for $SGMT, check out Quiver Quantitative's $SGMT forecast page.
$SGMT Price Targets
Multiple analysts have issued price targets for $SGMT recently. We have seen 6 analysts offer price targets for $SGMT in the last 6 months, with a median target of $28.5.
Here are some recent targets:
- Jonathan Wolleben from Citizens set a target price of $35.0 on 11/14/2025
- Kaveri Pohlman from Clear Street set a target price of $29.0 on 10/22/2025
- Edward Nash from Canaccord Genuity set a target price of $28.0 on 10/02/2025
- Yun Zhong from Wedbush set a target price of $28.0 on 08/11/2025
- Brandon Folkes from HC Wainwright & Co. set a target price of $29.0 on 08/07/2025
- Debanjana Chatterjee from Jones Trading set a target price of $27.0 on 06/06/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
